Introduction
Parkinson’s disease (PD) is typically linked to movement deficits that result from dopamine insufficiency in the substantia nigra pars compacta. However, non-motor symptoms (NMS) have recently drawn increasing attention. They result from dopaminergic impairment and other neurotransmitter systems such as the P substance, acetylcholine, serotonin and norepinephrine. They can also be caused by disordered protein aggregation of Lewy bodies in several parts of the nervous system or by the secondary effects of motor compromise.1 These two facts make these symptoms even more relevant. First, some symptoms, such as hyposmia, REM sleep disorder, constipation and depression, may manifest many years before the motor symptoms.2 Second, at a later stage of the disease, NMS are the main sources of the functional decline observed in patients.1 2 Therefore, it is crucial to understand the clinical non-motor picture to develop diagnostic and early intervention strategies. This would lead to better clinical and functional management as well as an increase in the quality of life of patients at the early stages of the disease.3
Dysfunctions of the central and peripheral nervous systems and other organic systems vary in the intensity and sequence of manifestation.1 As a result, the pharmacological approach to these dysfunctions is still limited, leaving an important gap in the global treatment of people with PD, since the dopamine precursors and agonists that are currently used have little or no effect on NMS.3
A non-pharmacological strategy broadly known as beneficial to improve the motor function and, to some extent, the NMS in PD is the utilisation of physical exercises and their different modalities.4 5 Exercise is defined as a type of physical activity that consists of planned, structured and repetitive bodily movement done to improve and/or maintain one or more components of physical fitness, which can be health—or skill-related.6
Although the most effective exercise modalities and better prescription strategies are yet to be investigated scientifically, it is accepted that physical exercise plays an important role in the maintenance of functionality and quality of life of patients with PD.7 In particular, aerobic and resistance exercises are modalities that activate physiological mechanisms, such as the relief of certain hormones, neurotransmitters and cytokines locally and further in the blood chain and thereby in the central nervous system, generating changes at the muscular and central level.8 9
Given the systemic effect of physical exercise and its potential use as a symptomatic intervention in PD, it is important to understand the effects of these exercises (and the different modalities) on the NMS of PD. Some reviews have already highlighted this question.4 However, because of the diversity of NMS and the fact that many of them were not considered as primary outcomes in previous studies, systematic reviews that amplify the search to embody evidence from primary and secondary non-motor outcomes may contribute to a clearer picture of the current evidence surrounding the use of physical exercise as an intervention for those symptoms.
NMS are measured clinically through validated scales, such as Part I of the Unified Parkinson’s Disease Rating Scale (UPDRS I) and the Non-Motor Symptoms Scale for Parkinson’s Disease (NMSS). These scales measure the presence and severity of a wide range of problems at all stages of PD, although they do not differentiate the nature of these symptoms, that is, whether they are direct results of PD only, but their impact on the disease.4 They give a common score that can be used to evaluate the progress of NMS as well as their improvement, resulting from therapies. Thus, our aim was to verify the effects of physical exercise on the NMS of PD, as assessed by validated general symptom scales.